Pd-Rx Pharmaceutical
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing s… Read more
Pd-Rx Pharmaceutical (PDRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2016: 0.166x
Based on the latest financial reports, Pd-Rx Pharmaceutical (PDRX) has a cash flow conversion efficiency ratio of 0.166x as of June 2016.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.86 Million) by net assets ($11.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pd-Rx Pharmaceutical - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Pd-Rx Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pd-Rx Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pd-Rx Pharmaceutical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ASOS (DYQ.SG)
STU:DYQ
|
N/A |
|
Harbin Electric Co Ltd
STU:HP6H
|
N/A |
|
TFCO4F
SA:TFCO4F
|
N/A |
|
Iren SpA
MU:TZ8
|
0.101x |
|
Casa Grande S.A.A.
LIM:CASAGRC1
|
N/A |
|
123fahrschule SE
DU:123F
|
-0.004x |
|
Mobile Max-M
TA:MBMX
|
-3.104x |
|
Telecom Egypt Company S.A.E
LSE:TEEG
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Pd-Rx Pharmaceutical (2013–2025)
The table below shows the annual cash flow conversion efficiency of Pd-Rx Pharmaceutical from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $10.24 Million | $765.03K | 0.075x | +158.05% |
| 2024-06-30 | $10.50 Million | $-1.35 Million | -0.129x | -180.96% |
| 2023-06-30 | $11.25 Million | $1.79 Million | 0.159x | -44.18% |
| 2022-06-30 | $11.36 Million | $3.24 Million | 0.285x | +618.62% |
| 2021-06-30 | $8.48 Million | $-465.77K | -0.055x | +37.97% |
| 2020-06-30 | $6.63 Million | $-586.54K | -0.089x | -118.60% |
| 2019-06-30 | $7.01 Million | $-283.88K | -0.040x | -203.62% |
| 2018-06-30 | $10.80 Million | $421.90K | 0.039x | -53.69% |
| 2017-06-30 | $11.34 Million | $956.49K | 0.084x | -49.15% |
| 2016-06-30 | $11.23 Million | $1.86 Million | 0.166x | +803.85% |
| 2015-06-30 | $10.77 Million | $197.67K | 0.018x | -91.84% |
| 2014-06-30 | $10.26 Million | $2.31 Million | 0.225x | +280.51% |
| 2013-06-30 | $8.46 Million | $500.02K | 0.059x | -- |